The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

A number of different strategies can be developed to protect people against atherosclerosis or to treat patients with clinical symptoms thereof. In our opinion, DNA and protein vaccination in ...

Background Left ventricular (LV) mass is closely associated with atherosclerotic heart disease, but the mechanisms are not ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

Two conditions within this category are atherosclerosis and arteriosclerosis, which are often confused. Both conditions involve changes in the arterial walls. However, arteriosclerosis is the ...

In atherosclerosis, the vascular smooth muscle cell (VSMC) contributes to vessel wall inflammation and lipoprotein retention, as well as to the formation of the fibrous cap that provides stability ...

A research team led by Prof. WENG Jianping from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS) revealed that insulin-like growth factor-binding ...

A new study linked COVID-19 with the rapid growth of plaque in the coronary arteries. This plaque is a high-risk type prone ...

Our opinion: At this point, we do not recommend changing exercise habits (including intensity) in asymptomatic athletes to reduce progression of coronary atherosclerosis, since current cross-sectional ...

Microplastics pose a threat to heart health, causing harmful changes in vascular cells and increasing the risk of cardiovascular diseases like atherosclerosis.

Market growth is primarily driven by the widespread use of cholesterol-lowering medications to prevent or reduce arterial blockages. Lifestyle changes, including poor dietary habits and reduced ...